ProPhase Labs, Inc.
PRPH
$0.3521
$0.041913.51%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -2.48M | 3.15M | 2.47M | 3.63M | -5.90M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.48M | 3.15M | 2.47M | 3.63M | -5.90M |
| Cost of Revenue | -3.41M | 3.31M | 2.95M | 4.07M | -2.16M |
| Gross Profit | 924.00K | -165.00K | -476.00K | -433.00K | -3.74M |
| SG&A Expenses | 15.43M | 7.65M | 7.21M | 7.59M | 6.96M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.08M | 11.08M | 10.30M | 11.93M | 5.06M |
| Operating Income | -14.57M | -7.94M | -7.83M | -8.30M | -10.96M |
| Income Before Tax | -15.96M | -9.10M | -8.44M | -8.83M | -11.26M |
| Income Tax Expenses | 14.56M | -2.51M | -2.29M | -2.57M | -2.91M |
| Earnings from Continuing Operations | -30.52M | -6.59M | -6.15M | -6.27M | -8.35M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -34.36M | -6.59M | -6.15M | -6.27M | -8.75M |
| EBIT | -14.57M | -7.94M | -7.83M | -8.30M | -10.96M |
| EBITDA | -14.07M | -5.55M | -6.21M | -6.61M | -9.34M |
| EPS Basic | -1.59 | -0.35 | -0.33 | -0.35 | -0.50 |
| Normalized Basic EPS | -0.40 | -0.30 | -0.28 | -0.31 | -0.40 |
| EPS Diluted | -1.59 | -0.35 | -0.33 | -0.35 | -0.50 |
| Normalized Diluted EPS | -0.40 | -0.30 | -0.28 | -0.31 | -0.40 |
| Average Basic Shares Outstanding | 20.46M | 19.08M | 18.89M | 18.05M | 17.21M |
| Average Diluted Shares Outstanding | 20.46M | 19.08M | 18.89M | 18.05M | 17.21M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |